Neuroscience and Beyond: Harnessing Computational Technology and Allosteric Modulators to Drug the Undruggable Additional details on registration, speakers and agendas to follow and will be posted under the Events section of the Gain Website. About Gain Therapeutics, Inc. Gain Therapeutics, Inc. is positioned at the confluence of technology and healthcare and focused on redefining drug discovery with its SEE-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment...

Read More Read More